Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ONEG | OneConstruction Group | $5.08 | -$5.18 | -50.49% | 2.2M | $164.2M | $1.48$13.50 |
| TSSI | Tss | $8.46 | -$6.79 | -44.52% | 6.6M | $432.6M | $5.63$31.94 |
| GWH | ESS Tech | $2.80 | -$1.45 | -34.12% | 1.4M | $83.4M | $0.76$13.87 |
| AVXL | Anavex Life Sciences | $3.85 | -$1.85 | -32.42% | 423.1K | $488.7M | $2.93$14.44 |
| SGBX | Safe & Green | $2.23 | -$0.93 | -29.53% | 2.9M | $1.5M | $1.81$122.88 |
| SOC | Sable Offshore | $4.27 | -$1.63 | -27.59% | 505.8K | $586.1M | $4.25$35.00 |
| STUB | StubHub | $14.68 | -$4.14 | -22.00% | 11.5M | $6.9B | $12.91$27.89 |
| ATGL | Alpha Technology Group | $11.25 | -$2.75 | -19.64% | 59 | $213.7M | $8.79$57.32 |
| LRHC | La Rosa | $2.47 | -$0.55 | -18.26% | 221.9K | $3.7M | $2.39$95.20 |
| GAUZ | Gauzy | $3.34 | -$0.69 | -17.04% | 776.3K | $75.3M | $1.98$13.00 |
Related Articles
Featured Article
Wall Street Thinks This Small-Cap Stock Can Quadruple in Value
David Jagielski|Mar 15, 2023
The company generates no revenue, but it may be worth taking a chance on as it possesses lots of upside.
Is Anavex Life Sciences Stock a Buy Now?
David Jagielski|Feb 23, 2023
A short squeeze could be a possibility if the company can prove that bearish investors are wrong about its business.
This Short-Squeeze Candidate Could Actually Pan Out in the Long Run
George Budwell|Feb 9, 2023
Short-sellers have piled into this clinical-stage biopharma stock.
Anavex Life Sciences Stock Could 5x Before 2025 -- Here's Why
Alex Carchidi|Dec 17, 2022
The biotech will first need to assuage the concerns of experts by elaborating on its latest clinical trial data.
Is Anavex Life Sciences a Buy?
Alex Carchidi|Dec 13, 2022
It still needs to prove that its lead program is as effective as it claims for treating Alzheimer's.
Is Anavex Life Sciences a Smart Stock to Buy Now?
Cory Renauer|Dec 3, 2022
The company's Alzheimer's disease drug just succeeded in a clinical trial. Or did it?
2 Biotech Stocks Set to Go Supernova Soon
George Budwell|Oct 18, 2021
Anavex Life Sciences and Affimed both sport unique drug development platforms that could be worth billions.
3 Biotech Stocks That Have Already Doubled This Year
Cory Renauer|Feb 20, 2020
Can these soaring biotech stocks keep climbing?
Forget Anavex Life Sciences Corp.: These 2 Biotech Stocks Are Better Buys
Cory Renauer|Feb 1, 2017
The tiny biotech's only clinical-stage candidate is a long way from the goal line, making these two biotech stocks far better picks.
Anavex Life Sciences Corp. in 3 Charts
Keith Speights|Dec 6, 2016
These charts show where things stand -- and where they could be headed -- for Alzheimer's disease drug developer Anavex Life Sciences.
